Description
ONO-1078 is a novel leukotriene antagonist that inhibits and reverses human bronchial contraction induced by leukotrienes C4 and D4 and antigen in vitro. It also shows concentration dependent inhibition and reverses contraction of isolated human bronchus induced by LTC4 and LTD4 and antigen. ONO-1078 was 100 times more potent than FPL-55712 in inhibiting LTC4 induced contractions.
ONO-1078 is a novel leukotriene antagonist that inhibits and reverses human bronchial contraction induced by leukotrienes C4 and D4 and antigen in vitro. It also shows concentration dependent inhibition and reverses contraction of isolated human bronchus induced by LTC4 and LTD4 and antigen. ONO-1078 was 100 times more potent than FPL-55712 in inhibiting LTC4 induced contractions.
Alternate Name/Synonyms: N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4(4-phenylbutoxy)benzamide
Appearance: White Solid
Formulation: N/A
CAS Number: 103177-37-3
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₇H₂₃N₅O₄
Molecular Weight: 481.5
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO (>20 mg/ml)
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A novel leukotriene antagonist that inhibits and reverses human bronchial contraction induced by leukotrienes C4 and D4
MDL Number: MFCD00864631
PubChem CID: 4887
SMILES: 1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC4=C(C=C3)C(=O)C=C(O4)C5=NNN=N5
InChi: InChI=1S/C27H23N5O4/c33-23-17-25(26-29-31-32-30-26)36-24-16-20(11-14-22(23)24)28-27(34)19-9-12-21(13-10-19)35-15-5-4-8-18-6-2-1-3-7-18/h1-3,6-7,9-14,16-17H,4-5,8,15H2,(H,28,34)(H,29,30,31,32)
InChi Key: UAJUXJSXCLUTNU-UHFFFAOYSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |